Test Code PCS4WO Pain Clinic Survey 4 Without Confirmation, Urine
Useful For
Immunoassay screen (presumptive results) for tests not covered in the "Targeted Drug Panel, Urine" (TDPU).
Synonyms/Keywords
Drug screen, drug test, barbiturates, cannabinoids, marijuana, THC, cocaine, ethanol
Specimen Requirements
| Fasting Required | Specimen Type | Preferred Container/Tube | Acceptable Container/Tube | Specimen Volume | Specimen Minimum Volume (allows for 1 repeat) |
Pediatric Minimum Volume (no repeat) |
|---|---|---|---|---|---|---|
| No | Urine | Clean plastic container | 5 mL | 1.5 mL | 1.5 mL |
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Urine | Refrigerated | 3 days |
| Frozen | >3 days |
Test Components
Immunoassay screen for the following drug classes or method groups: barbiturates, cannabinoids, cocaine, and ethanol. Test also includes specimen validity testing (creatinine) to detect adulteration, dilution, or substitution of the specimen.
Results of this test are presumptive. If confirmatory testing is desired, the confirmatory test(s) can be ordered as add-on (u-have) tests, utilizing the original urine collection, within 9 days of the original test.
This test is intended to compliment the test "Targeted Drug Panel, Urine" (TDPU).
Test Information
This is a screening-only assay performed on urine specimens and is designed to support medical, not forensic, purposes. The detection of drug classes listed in this survey is to be used for compliance monitoring and identification of abuse.
This test recognizes the following drug classes utilizing immunoassay reagents: barbiturates, cannabinoids, cocaine, and ethanol. Test includes specimen validity testing (creatinine) to detect adulteration, dilution, or substitution of the specimen.
Immunoassay is useful in detecting truly negative samples. However, each immunoassay is more sensitive to some components of the drug class than others, and cross-reactivity of other substances can interfere or alter results. Therefore, this test is intended to be used by a physician or trained provider and interpreted in the context of the patient's symptoms and history.
Positive results are not definitive, and should be considered presumptive. Any presumptive positive results should be confirmed before the results are acted upon. The advantage of this test is that it is low-cost to the patient, and in most cases will give enough information to determine if the patient is adhering to the guidelines of their particular pain management program.
Specimens are kept for 9 business days from the screening date. If confirmation testing is desired to accurately determine what drugs the patient is positive for, please or the additional testing or call the laboratory at 93734 within this timeframe. If specimen is available, confirmation testing can be ordered at an additional charge. For specific details of what drugs are detected in each confirmation assay, please refer to the information provided with those specific test codes or inquire with the laboratory's technical staff before ordering.
Interferences
Immunoassay is useful in detecting truly negative samples. However, each immunoassay is more sensitive to some components of the drug class than others, and cross-reactivity of other substances can interfere or alter results. Therefore, this test is intended to be used by a physician or trained provider and interpreted in the context of the patient’s symptoms and history.
Interpretations
Drug classes are reported as "Presumptive Positive" or "Negative". Specific drugs within these drug classes are not reported, and would require confirmatory testing if this information is desired.
Results should be confirmed before acting on results.
Reference Range Information
| Performing Location | Reference Range |
|---|---|
| Marshfield | No reference range for drugs found in urine. Presence of drug indicates ingestion/use only, and is not to be used for therapeutic drug monitoring. |
Marshfield Labs Performing Department
Marshfield Labs Chemistry
Performing Information
| Performing Location | Day(s) Test Performed | Analytical Time | Methodology/Instrumentation |
|---|---|---|---|
| Marshfield | Monday through Friday | 1 days | Beckman DxC 700 AU/Emit Immunoassay |
CPT Codes
| CPT | Modifier (if needed) |
Quantity | Description | Comments |
|---|---|---|---|---|
| 80307 | 1 | Drug test(s),presumptive, any number of drug classes, qualitative; any number of devices or procedures, byinstrument chemistry and analyzers (e.g., utilizing immunoassay [EIA, ELISA,EMIT, FPIA, IA, KIMS, RIA]), chromatography (e.g., GC, HPLC), and mass spectrometry either with orwithout chromatography |
Outreach CPT Codes
| CPT | Modifier (if needed) |
Quantity | Description | Comments |
|---|---|---|---|---|
| 80307 | 1 | Drug test(s), presumptive, any number of drug classes, qualitative; any number of devices or procedures, by instrument chemistry and analyzers (e.g., utilizing immunoassay [EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (e.g., GC, HPLC), and mass spectrometry either with or without chromatography |
Ordering Applications
| Ordering Application | Description |
|---|---|
| Cerner | Pain Clinic 4 w/o Confirm |